PTEN is a predictive biomarker of trastuzumab resistance and prognostic factor in HER2-overexpressing gastroesophageal adenocarcinoma

Poor trastuzumab (Tmab) response of patients with human epidermal growth factor receptor 2-overexpressing gastric or gastroesophageal junction adenocarcinoma (HER2-GEA) is associated with the inhibition of phosphatase and tensin homolog (PTEN) expression. In this multicenter, retrospective observati...

Descripción completa

Detalles Bibliográficos
Autores principales: Yokoyama, Daiju, Hisamori, Shigeo, Deguchi, Yasunori, Nishigori, Tatsuto, Okabe, Hiroshi, Kanaya, Seiichiro, Manaka, Dai, Kadokawa, Yoshio, Hata, Hiroaki, Minamiguchi, Sachiko, Tsunoda, Shigeru, Obama, Kazutaka, Sakai, Yoshiharu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079403/
https://www.ncbi.nlm.nih.gov/pubmed/33907203
http://dx.doi.org/10.1038/s41598-021-88331-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079403/
https://www.ncbi.nlm.nih.gov/pubmed/33907203
http://dx.doi.org/10.1038/s41598-021-88331-3

Ejemplares similares